ArticleAging2024

Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.

Xinli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.